Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-24

Clinical Trial Update: Varenicline for "Gradual" vs. "Abrupt" Smoking Cessation in Low-motivated COPD Smokers [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating varenicline for gradual versus abrupt smoking cessation in low-motivated COPD smokers; status is unknown/not reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)

Snippet

Sponsor: Shaare Zedek Medical Center | Conditions: Smoking Cessation | Phase 4 | Status: UNKNOWN